相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brentuximab vedotin in anaplastic large cell lymphoma
Alan P. Z. Skarbnik et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis
Ivan Alvarez-Twose et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion
Jose Mario T. Morgado et al.
MODERN PATHOLOGY (2012)
Brentuximab vedotin
Niels W. C. J. van de Donk et al.
MABS (2012)
Primary Role of Multiparametric Flow Cytometry in the Diagnostic Work-Up of Indolent Clonal Mast Cell Disorders
Omar Perbellini et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2011)
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis
Karl Sotlar et al.
MODERN PATHOLOGY (2011)
Evaluation of the WHO criteria for the classification of patients with mastocytosis
Laura Sanchez-Munoz et al.
MODERN PATHOLOGY (2011)
Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms
Peter Valent et al.
LEUKEMIA & LYMPHOMA (2011)
Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes
Cristina Teodosio et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders:: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients
Andres C. Garcia-Montero et al.
BLOOD (2006)
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
C Akin et al.
BLOOD (2004)
Immunophenotypic analysis of mast cells in mastocytosis:: When and how to do it.: Proposals of the Spanish network on mastocytosis (REMA)
L Escribano et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2004)
Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro
K Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2004)
Selecting fluorochrome conjugates for maximum sensitivity
HT Maecker et al.
CYTOMETRY PART A (2004)
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease
D Molin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis
WR Sperr et al.
LEUKEMIA RESEARCH (2001)
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings
HP Horny et al.
LEUKEMIA RESEARCH (2001)
分享论文
